Finally, it would be interesting to analyse the effect of each medication of the class separately, however due to the small number of studies with each one of them this analysis would lack power
And Im not the only one who feels this way
Affectionately called 'Lizzie, or Gilly' by diabetic patients and marketed as 'Byetta', exenatide was the first slow-release GLP-1 mimic to reach the market (Schuler, Shearin)
Premium Care, Honest Pricing We are proud to offer the lowest price for medically supervised GLP-1 therapy in Southlake
Lee: Patient behavior can absolutely play a role
Previous clinical and preclinical studies have been contradictory, says co-corresponding author Yonggui Yuan of Southeast University in Jiangsu, China